Literature DB >> 21664689

Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides.

Christopher J Cheng1, W Mark Saltzman.   

Abstract

We have developed a polymer nanoparticle-based siRNA delivery system that exploits a cell surface binding synergism between targeting ligands and cell-penetrating peptides. Nanoparticles were coated with folate and penetratin via a PEGylated phospholipid linker (DSPE-PEG): the combination of both of these ligands represents a strategy for enhancing intracellular delivery of attached polymer nanoparticles. Nanoparticles were characterized for size, morphology, density of surface modification, and ligand association and retention. The surface coverage achieved on DSPE-PEG-coated nanoparticles is as high as (or higher than) obtained with other ligand-modified nano-scale particulate systems (∼0.5-5 pmol ligand/cm²). Additionally, these nanoparticles were loaded with a high density of siRNA (∼130-140 pmol siRNA/mg nanoparticles), which is slowly released upon incubation in water. Synergies between the activity of surface binding and cell internalizing ligands on these siRNA-loaded nanoparticles impart delivery enhancements that improve their gene silencing efficacy both in culture and in tumor models. Traditionally, targeting ligands function by binding to cell surface receptors, while cell-penetrating peptides function by nonspecifically transporting across cell membranes. Interestingly, we have observed that improved delivery of these dual-functionalized nanoparticles was in part, a result of increased cell surface avidity afforded by both ligands. This siRNA delivery system presents an approach to surface modification of nanovehicles, in which multiple ligands function in parallel to enhance cell binding and uptake.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21664689      PMCID: PMC3130098          DOI: 10.1016/j.biomaterials.2011.04.053

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  45 in total

Review 1.  Regulated portals of entry into the cell.

Authors:  Sean D Conner; Sandra L Schmid
Journal:  Nature       Date:  2003-03-06       Impact factor: 49.962

2.  Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake.

Authors:  Jean Philippe Richard; Kamran Melikov; Eric Vives; Corinne Ramos; Birgit Verbeure; Mike J Gait; Leonid V Chernomordik; Bernard Lebleu
Journal:  J Biol Chem       Date:  2002-10-30       Impact factor: 5.157

3.  The antennapedia peptide penetratin translocates across lipid bilayers - the first direct observation.

Authors:  P E Thorén; D Persson; M Karlsson; B Nordén
Journal:  FEBS Lett       Date:  2000-10-06       Impact factor: 4.124

4.  Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis.

Authors:  Joanna Rejman; Volker Oberle; Inge S Zuhorn; Dick Hoekstra
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

Review 5.  Folate receptor-targeted drugs for cancer and inflammatory diseases.

Authors:  Philip S Low; Asok C Antony
Journal:  Adv Drug Deliv Rev       Date:  2004-04-29       Impact factor: 15.470

6.  Generation of stable cell lines expressing GFP-tubulin and photoactivatable-GFP-tubulin and characterization of clones.

Authors:  Holly V Goodson; Jill S Dzurisin; Patricia Wadsworth
Journal:  Cold Spring Harb Protoc       Date:  2010-09-01

7.  Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and tat: a kinetic and efficacy study.

Authors:  Yun-Long Tseng; Jun-Jen Liu; Ruey-Long Hong
Journal:  Mol Pharmacol       Date:  2002-10       Impact factor: 4.436

8.  Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans.

Authors:  Sandra Console; Cornelia Marty; Carlos García-Echeverría; Reto Schwendener; Kurt Ballmer-Hofer
Journal:  J Biol Chem       Date:  2003-06-30       Impact factor: 5.157

9.  Surface-engineered nanoparticles for multiple ligand coupling.

Authors:  Ruxandra Gref; Patrick Couvreur; Gillian Barratt; Evgueni Mysiakine
Journal:  Biomaterials       Date:  2003-11       Impact factor: 12.479

Review 10.  Ligand-targeted therapeutics in anticancer therapy.

Authors:  Theresa M Allen
Journal:  Nat Rev Cancer       Date:  2002-10       Impact factor: 60.716

View more
  41 in total

1.  Modified poly(lactic-co-glycolic acid) nanoparticles for enhanced cellular uptake and gene editing in the lung.

Authors:  Rachel J Fields; Elias Quijano; Nicole Ali McNeer; Christina Caputo; Raman Bahal; Kavi Anandalingam; Marie E Egan; Peter M Glazer; W Mark Saltzman
Journal:  Adv Healthc Mater       Date:  2014-08-25       Impact factor: 9.933

2.  Octa-functional PLGA nanoparticles for targeted and efficient siRNA delivery to tumors.

Authors:  Jiangbing Zhou; Toral R Patel; Michael Fu; James P Bertram; W Mark Saltzman
Journal:  Biomaterials       Date:  2011-10-19       Impact factor: 12.479

3.  Synergistic tumor suppression by combined inhibition of telomerase and CDKN1A.

Authors:  Romi Gupta; Yuying Dong; Peter D Solomon; Hiromi I Wettersten; Christopher J Cheng; Jin-Na Min; Jeremy Henson; Shaillay Kumar Dogra; Sung H Hwang; Bruce D Hammock; Lihua J Zhu; Roger R Reddel; W Mark Saltzman; Robert H Weiss; Sandy Chang; Michael R Green; Narendra Wajapeyee
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-14       Impact factor: 11.205

4.  Lipid modified triblock PAMAM-based nanocarriers for siRNA drug co-delivery.

Authors:  Swati Biswas; Pranali P Deshpande; Gemma Navarro; Namita S Dodwadkar; Vladimir P Torchilin
Journal:  Biomaterials       Date:  2012-11-05       Impact factor: 12.479

5.  Poly(amine-co-ester) nanoparticles for effective Nogo-B knockdown in the liver.

Authors:  Jiajia Cui; Alexandra S Piotrowski-Daspit; Junwei Zhang; Mingjie Shao; Laura G Bracaglia; Teruo Utsumi; Young-Eun Seo; Jenna DiRito; Eric Song; Christine Wu; Asuka Inada; Gregory T Tietjen; Jordan S Pober; Yasuko Iwakiri; W Mark Saltzman
Journal:  J Control Release       Date:  2019-05-01       Impact factor: 9.776

6.  Rational design of a biomimetic cell penetrating peptide library.

Authors:  Emmanouil D Karagiannis; Aleksandra M Urbanska; Gaurav Sahay; Jeisa M Pelet; Siddharth Jhunjhunwala; Robert Langer; Daniel G Anderson
Journal:  ACS Nano       Date:  2013-09-30       Impact factor: 15.881

7.  A complementary strategy for enhancement of nanoparticle intracellular uptake.

Authors:  Yingjia Li; Ge Wen; Dongxiao Wang; Xia Zhang; Yaoyong Lu; Jianguo Wang; Lijuan Zhong; Hongbing Cai; Xingmei Zhang; Ying Wang
Journal:  Pharm Res       Date:  2014-02-21       Impact factor: 4.200

8.  Systemic delivery of triplex-forming PNA and donor DNA by nanoparticles mediates site-specific genome editing of human hematopoietic cells in vivo.

Authors:  N A McNeer; E B Schleifman; A Cuthbert; M Brehm; A Jackson; C Cheng; K Anandalingam; P Kumar; L D Shultz; D L Greiner; W Mark Saltzman; P M Glazer
Journal:  Gene Ther       Date:  2012-10-18       Impact factor: 5.250

Review 9.  Crossing the barrier: treatment of brain tumors using nanochain particles.

Authors:  Efstathios Karathanasis; Ketan B Ghaghada
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-01-09

10.  Surface modified poly(β amino ester)-containing nanoparticles for plasmid DNA delivery.

Authors:  Rachel J Fields; Christopher J Cheng; Elias Quijano; Caroline Weller; Nina Kristofik; Nha Duong; Christopher Hoimes; Marie E Egan; W Mark Saltzman
Journal:  J Control Release       Date:  2012-10-05       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.